Subject: NCI Bid Board Posting – Service agreement for Mantra Imaging SystemService Agreement • October 5th, 2021
The goal of the Molecular Imaging Branch (MIB) is to develop targeted imaging methods that accelerate the development of cancer therapies. The MIB is focused on the development and translation of in vivo molecular imaging agents for early detection, monitoring and therapy. Given the high risks and high costs of conducting research in this field, the MIB is well positioned to address the challenges that the field of molecular imaging faces. The Molecular Imaging Clinic conducts early phase trials of molecular imaging agents. MIB investigate diagnostic imaging agents that employ nuclear, optical or magnetic resonance reporters in human subjects.